Parametric Portfolio Associates’s Insmed INSM Stock Holding History

Parametric Portfolio Associates’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2M	Sell	85,312 -18,330	-18%	-$426K	﹤0.01%	2422
2021 Q4	$2.82M	Buy	103,642 +3,107	+3%	+$88.8K	﹤0.01%	2235
2021 Q3	$2.77M	Buy	100,535 +9,738	+11%	+$255K	﹤0.01%	2220
2021 Q2	$2.58M	Sell	90,797 -2,928	-3%	-$86.9K	﹤0.01%	2292
2021 Q1	$3.19M	Buy	93,725 +6,749	+8%	+$258K	﹤0.01%	2475
2020 Q4	$2.9M	Buy	86,976 +6,419	+8%	+$234K	﹤0.01%	2423
2020 Q3	$2.59M	Sell	80,557 -347	-0.4%	-$9.97K	﹤0.01%	2345
2020 Q2	$2.23M	Sell	80,904 -3,913	-5%	-$92.8K	﹤0.01%	2431
2020 Q1	$1.36M	Sell	84,817 -50,507	-37%	-$1.2M	﹤0.01%	2613
2019 Q4	$3.23M	Sell	135,324 -8,776	-6%	-$179K	﹤0.01%	2362
2019 Q3	$2.54M	Buy	144,100 +50,984	+55%	+$985K	﹤0.01%	2487
2019 Q2	$2.38M	Buy	93,116 +31,598	+51%	+$880K	﹤0.01%	2549
2019 Q1	$1.79M	Sell	61,518 -8,016	-12%	-$208K	﹤0.01%	2721
2018 Q4	$912K	Buy	69,534 +5,502	+9%	+$87.8K	﹤0.01%	3040
2018 Q3	$1.29M	Sell	64,032 -25,955	-29%	-$586K	﹤0.01%	2957
2018 Q2	$2.13M	Buy	89,987 +60,403	+204%	+$1.55M	﹤0.01%	2651
2018 Q1	$666K	Sell	29,584 -31,001	-51%	-$816K	﹤0.01%	3207
2017 Q4	$1.89M	Buy	60,585 +6,170	+11%	+$182K	﹤0.01%	2647
2017 Q3	$1.7M	Buy	54,415 +38,380	+239%	+$731K	﹤0.01%	2698
2017 Q2	$275K	Buy	16,035 +1,618	+11%	+$27.6K	﹤0.01%	3676
2017 Q1	$252K	Buy	14,417 +4,063	+39%	+$62.7K	﹤0.01%	3501
2016 Q4	$137K	Buy	+10,354	New	+$141K	﹤0.01%	3665
2015 Q3	–	Sell	-10,492	Closed	-$256K	–	3303
2015 Q2	$256K	Buy	+10,492	New	+$238K	﹤0.01%	3653
2015 Q1	–	Sell	-26,535	Closed	-$410K	–	3970
2014 Q4	$410K	Sell	26,535 -1,766	-6%	-$25.1K	﹤0.01%	3379
2014 Q3	$369K	Sell	28,301 -6,822	-19%	-$103K	﹤0.01%	3373
2014 Q2	$702K	Buy	35,123 +1,068	+3%	+$15.8K	﹤0.01%	2989
2014 Q1	$648K	Buy	34,055 +7,327	+27%	+$139K	﹤0.01%	3009
2013 Q4	$454K	Buy	26,728 +7,556	+39%	+$116K	﹤0.01%	3232
2013 Q3	$299K	Buy	+19,172	New	+$244K	﹤0.01%	3395

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Parametric Portfolio Associates's INSM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Insmed (INSM) stake by 18% in Q1 2022, selling an estimated $426K and leaving 85,312 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2422.

Parametric Portfolio Associates first reported a position in INSM in Q3 2013 and has held it in 29 quarters since. The position peaked at $3.23M in Q4 2019. 225 funds tracked by Wall St. Rank hold INSM as of Q1 2022.

Parametric Portfolio Associates held 85,312 shares of Insmed worth $2M as of Q1 2022.
Parametric Portfolio Associates sold 18,330 Insmed shares in Q1 2022, an estimated $426K.
Insmed made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2422 holding.
Parametric Portfolio Associates first reported a position in Insmed in Q3 2013 and has held it in 29 quarters since.
Parametric Portfolio Associates's Insmed position peaked at $3.23M in Q4 2019.
225 funds tracked by Wall St. Rank held Insmed as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.